非肽类蛋白酶抑制剂(NPPIs):替普那韦

{"title":"非肽类蛋白酶抑制剂(NPPIs):替普那韦","authors":"D. Mayers, K. Curry, V. Kohlbrenner, S. McCallister","doi":"10.1016/S1075-8593(03)04003-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92864,"journal":{"name":"Advances in antiviral drug design","volume":"4 1","pages":"79-98"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1075-8593(03)04003-6","citationCount":"1","resultStr":"{\"title\":\"Non-peptidic protease inhibitors (NPPIs): Tipranavir\",\"authors\":\"D. Mayers, K. Curry, V. Kohlbrenner, S. McCallister\",\"doi\":\"10.1016/S1075-8593(03)04003-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":92864,\"journal\":{\"name\":\"Advances in antiviral drug design\",\"volume\":\"4 1\",\"pages\":\"79-98\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1075-8593(03)04003-6\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in antiviral drug design\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/S1075-8593(03)04003-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in antiviral drug design","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/S1075-8593(03)04003-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}